Fluorescent immunolabeling of cancer cells by quantum dots and antibody scFv fragment.
暂无分享,去创建一个
Ilya V Turchin | Sergey M Deyev | E. N. Lebedenko | O. Stremovskiy | S. Deyev | I. Turchin | S. Dorofeev | I. Balalaeva | Tatiana A Zdobnova | Sergey G Dorofeev | Piter N Tananaev | Roman B Vasiliev | Taras G Balandin | Eveline F Edelweiss | Oleg A Stremovskiy | Irina V Balalaeva | Ekaterina N Lebedenko | Vladimir P Zlomanov | R. Vasiliev | V. Zlomanov | T. Balandin | T. Zdobnova | E. F. Edelweiss | P. N. Tananaev
[1] Sergey M Deyev,et al. Multivalency: the hallmark of antibodies used for optimization of tumor targeting by design. , 2008, BioEssays : news and reviews in molecular, cellular and developmental biology.
[2] V. Lobachov,et al. Key role of barstar Cys‐40 residue in the mechanism of heat denaturation of bacterial ribonuclease complexes with barstar , 1999, FEBS letters.
[3] L. Harris,et al. The HER2 extracellular domain as a prognostic and predictive factor in breast cancer. , 2002, Clinical breast cancer.
[4] R. Hartley,et al. Barnase and barstar. Expression of its cloned inhibitor permits expression of a cloned ribonuclease. , 1988, Journal of molecular biology.
[5] P. Mulvaney,et al. The effects of chemisorption on the luminescence of CdSe quantum dots. , 2006, Langmuir : the ACS journal of surfaces and colloids.
[6] Tomonobu M. Watanabe,et al. Reduction in nonfluorescence state of quantum dots on an immunofluorescence staining. , 2006, Biochemical and biophysical research communications.
[7] Andreas Plückthun,et al. Design of multivalent complexes using the barnase·barstar module , 2003, Nature Biotechnology.
[8] Shuming Nie,et al. Emerging use of nanoparticles in diagnosis and treatment of breast cancer. , 2006, The Lancet. Oncology.
[9] Igor Nabiev,et al. Biocompatible fluorescent nanocrystals for immunolabeling of membrane proteins and cells. , 2004, Analytical biochemistry.
[10] Anna M Wu,et al. Arming antibodies: prospects and challenges for immunoconjugates , 2005, Nature Biotechnology.
[11] M. Moasser,et al. The epidermal growth factor receptor family: Biology driving targeted therapeutics , 2008, Cellular and Molecular Life Sciences.
[12] A. Plückthun,et al. High thermal stability is essential for tumor targeting of antibody fragments: engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain Fv fragment. , 1999, Cancer research.
[13] S. Deyev,et al. Visualization of cancer cells by means of the fluorescent EGFP-barnase protein , 2007, Doklady Biochemistry and Biophysics.
[14] P. Trail,et al. Monoclonal antibody drug immunoconjugates for targeted treatment of cancer , 2003, Cancer Immunology, Immunotherapy.
[15] Noriaki Ohuchi,et al. In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice. , 2007, Cancer research.
[16] J. Ross,et al. The HER‐2/neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy , 1998, Stem cells.
[17] Xiaogang Peng,et al. Kinetics of II-VI and III-V Colloidal Semiconductor Nanocrystal Growth: “Focusing” of Size Distributions , 1998 .
[18] J. Matthew Mauro,et al. Self-Assembly of CdSe−ZnS Quantum Dot Bioconjugates Using an Engineered Recombinant Protein , 2000 .
[19] D. Dirin,et al. Synthesis and optical properties of PbSe and CdSe colloidal quantum dots capped with oleic acid , 2004 .
[20] K. Jain,et al. Applications of nanobiotechnology in clinical diagnostics. , 2007, Clinical chemistry.
[21] P. N. Wang,et al. Enhancement of Intracellular Delivery of CdTe Quantum Dots (QDs) to Living Cells by Tat Conjugation , 2007, Journal of Fluorescence.
[22] S. Nie,et al. In vivo cancer targeting and imaging with semiconductor quantum dots , 2004, Nature Biotechnology.
[23] D. Balding,et al. HLA Sequence Polymorphism and the Origin of Humans , 2006 .
[24] Noriaki Ohuchi,et al. In vivo single molecular imaging and sentinel node navigation by nanotechnology for molecular targeting drug-delivery systems and tailor-made medicine , 2008, Breast cancer.
[25] M. Bruchez,et al. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots , 2003, Nature Biotechnology.
[26] Masato Yasuhara,et al. Physicochemical Properties and Cellular Toxicity of Nanocrystal Quantum Dots Depend on Their Surface Modification , 2004 .
[27] K. D. Hardman,et al. Single-chain antigen-binding proteins. , 1988, Science.